The world health Organization (WHO) has hailed Tuesday as a “scientific breakthrough” after the announcement by british scientists as a medication in the family of steroids reduced significantly the mortality in seriously ill patients by the COVID-19.
“This is the first treatment proven to reduces the mortality in patients with by the COVID-19 under the assistance of oxygen or a respirator,” commented the director-general of WHO, Tedros Adhanom Ghebreyesus, in a press release.
“This is good news and I congratulate the british government, Oxford university and the many hospitals and patients in the United Kingdom who have contributed to this scientific breakthrough that saves lives”, he added.
The pandemic has killed at least 438 250 dead since the country is officially a state of the onset of the disease in December, according to a report drawn up by the AFP.
The hopes of finding a treatment widely available and cheap against the new coronavirus have been edged Tuesday by the announcement that leaders of the clinical trial uk Recovery had discovered that a steroid, dexamethasone, to reduce by one third the mortality in patients with the most severely affected.
According to them, “a death on eight could be avoided through this treatment for patients placed under mechanical ventilation”.
“This is a major breakthrough in the search for new ways to treat the sick, the Covid”, welcomed in a press release professor Stephen Powis, medical director of the NHS, the public health service of the uk.
This drug is already used in many indications for its anti-inflammatory effect powerful.
“The researchers have shared the first information about the results of the test with the WHO, and we sincerely hope to know the complete analysis of the data in the next few days,” added the WHO.
The WHO added that it would lead to a “meta-analysis” of such research in order to update its guidelines to “reflect how and when the drug should be used” against the disease.